No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use*
-
COVID-19 / epidemiology
-
Canada / epidemiology
-
Humans
-
Infant
-
Palivizumab / therapeutic use*
-
Pandemics
-
Practice Guidelines as Topic
-
Respiratory Syncytial Virus Infections / prevention & control*
-
SARS-CoV-2
Substances
-
Antiviral Agents
-
Palivizumab